Drug intelligence / Profile preview

Celtis occidentalis pollen

Development stage
Unknown
Lead developer
Jubilant HollisterStier
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Percutaneous, Subcutaneous, Sublingual
01

Overview

Celtis occidentalis pollen is a non-standardized, allergenic extract derived from the pollen of the common hackberry tree (Celtis occidentalis). [13] It is manufactured and marketed by Jubilant HollisterStier LLC under the brand name 'Pollens - Trees, Hackberry Celtis Occidentalis'. [3, 16] The product was first approved in the United States in 1941 and is used for both the diagnosis (via percutaneous skin testing) and treatment (via subcutaneous immunotherapy) of allergic conditions such as hay fever or rhinitis caused by sensitivity to hackberry pollen. [5, 8] While effective for sensitized individuals, hackberry pollen is generally considered to be less allergenic compared to other tree pollens. [13]

Brand names
Pollens - Trees, Hackberry Celtis Occidentalis
Other names
Hackberry pollen extractCommon hackberry pollenHackberry pollenAllergenic extract- hackberry celtis occidentalis68R9X9Y96X
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Celtis occidentalis pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celtis occidentalis pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call